Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zorzon

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's diseaseL Capus, A Melatini, M Zorzon, et al.
Neurology|October 10, 2001
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MSR Zivadinov, R A Rudick, R De Masi, et al.
European Journal of Neurology|July 20, 2004
beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosisF Bagnato, R Zivadinov, D Cecchinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.
European Journal of Neurology|September 11, 2002
Depressive symptoms and MRI changes in multiple sclerosisM Zorzon, R Zivadinov, D Nasuelli, et al.
European Journal of Neurology|June 17, 2005
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2007
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophyR Zivadinov, L Locatelli, D Cookfair, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 27, 2009
Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosisR Zivadinov, M Zorzon, B Weinstock-Guttman, et al.
La Radiologia Medica|June 26, 2012
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigueI Specogna, F Casagrande, A Lorusso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2001
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosisR Zivadinov, J Sepcic, D Nasuelli, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's diseaseL Capus, A Melatini, M Zorzon, et al.
Neurology|October 10, 2001
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MSR Zivadinov, R A Rudick, R De Masi, et al.
European Journal of Neurology|July 20, 2004
beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosisF Bagnato, R Zivadinov, D Cecchinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.
European Journal of Neurology|September 11, 2002
Depressive symptoms and MRI changes in multiple sclerosisM Zorzon, R Zivadinov, D Nasuelli, et al.
European Journal of Neurology|June 17, 2005
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 28, 2007
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophyR Zivadinov, L Locatelli, D Cookfair, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 27, 2009
Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosisR Zivadinov, M Zorzon, B Weinstock-Guttman, et al.
La Radiologia Medica|June 26, 2012
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigueI Specogna, F Casagrande, A Lorusso, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2001
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosisR Zivadinov, J Sepcic, D Nasuelli, et al.
Pageof 6